Journals / Tıp Fakültesi Klinikleri Dergisi / 2021 / Cilt: 4 - Sayı: 1

Covid-19 and Cancer

Covid-19 ve Kanser

Pages
1–14
Publication Date
2021-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will discuss the origin and pathology of Covid-19, why its mortality is higher in certain situations, as well as the effect of this disease on the life of cancer patients, complications in cancer patients diagnosed with Covid-19, the effect of inhibitors used in cancer treatment on Covid-19 and lastly guidelines and studies will be discussed for cancer patients in global pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SARS-CoV-2, the new member of the coronavirus family, is a virus that emerged in Wuhan, China in December 2019 and caused a pandemic all over the world.
📊
Key Findings & Data:This disease, called Covid-19, increases the risk of death in individuals over 65 years of age and with chronic diseases.
💡
Conclusion & Impact:In this review, we will discuss the origin and pathology of Covid-19, why its mortality is higher in certain situations, as well as the effect of this disease on the life of cancer patients, complications in cancer patients diagnosed with Covid-19, the effect of inhibitors used in cancer treatment on Covid-19 and lastly guidelines and studies will be discussed for cancer patients in global pandemic.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:SARS-CoV-2 · Covid-19 · Kanser

Abstract

SARS-CoV-2, the new member of the coronavirus family, is a virus that emerged in Wuhan, China in December 2019 and caused a pandemic all over the world. This disease, called Covid-19, increases the risk of death in individuals over 65 years of age and with chronic diseases. Cytokine Storm is one of the most serious mechanisms that trigger death in the pathogenesis of Covid-19. Although studies are ongoing for a vaccine against this disease or a drug that will affect its pathogenesis, an effective treatment method has not been found. The rapid spread of the virus and the increase in the number of cases have caused a problems in the health sector, and guidelines have been published to reduce the risk of infection of individuals who have not been diagnosed with Covid-19 but have serious illnesses such as cancer. In this review, we will discuss the origin and pathology of Covid-19, why its mortality is higher in certain situations, as well as the effect of this disease on the life of cancer patients, complications in cancer patients diagnosed with Covid-19, the effect of inhibitors used in cancer treatment on Covid-19 and lastly guidelines and studies will be discussed for cancer patients in global pandemic.

Özet

2019 Aralık Ayında Çin’in Wuhan şehrinde ortaya çıkan ve koronavirüs ailesinin yeni üyesi olan SARS-CoV-2 kısa sürede tüm Dünya’ya yayılmış ve pandemi ilan edilmesine neden olmuş bir virüstür. Covid-19 olarak adlandırılan bu hastalık kronik rahatsızlığı bulunan ve yaşı 65 üzeri olan bireylerde ölüm riskini arttırmaktadır. Covid-19’un patogenezinde ölümü tetikleyen en ciddi mekanizmaların başında oluşturduğu Sitokin Fırtınası gelmektedir. Günümüzde hastalığa karşı aşı veya bu mekanizmaları düzenleyecek bir ilaç araştırmaları devam etse de ne yazık ki henüz net bir tedavi yöntemi bulunmamaktadır. Hızlı yayılması ve vaka sayılarındaki artış sağlık sektöründe büyük bir yoğunluğa neden olduğu için Covid-19 tanısı konmayan fakat kanser gibi ciddi rahatsızlıkları olan bireylerin enfekte olma riskini azaltmaya yönelik kılavuzlar yayınlanmıştır. Bu derlemede Covid-19'un kökenini, patolojisini, neden mortalitesinin belirli durumlarda yüksek olduğunun yanı sıra bu hastalığın kanserli hastaların hayatına olan etkisi, Covid-19 tanısı konulan kanser hastalarının tedavisindeki komplikasyonlar ve kanser tedavisinde kullanılan inhibitörlerin Covid-19 üzerine etkisini kapsayan tedavi biçimlerini içeren kılavuz ve çalışmalar tartışılacaktır.

🔖

Cite This Article

TUNÇDEMİR, M., KARATAŞ, M. (2021). Covid-19 and Cancer. Tıp Fakültesi Klinikleri Dergisi, Cilt: 4 - Sayı: 1, 1–14. https://ajindex.com/articles/844583

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395:565–574
  2. Paraskevis D, Kostaki EG, Magiorkinis G et al. Tsiodras S Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 2020; 79:104212 Chen L, Liu W, Zhang Q et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microb Infect 2020; 9:313–319
  3. Yuki, K., Fujiogi, M., & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin Immunol 2020; 108427. Madabhavi, I., Sarkar, M., & Kadakol, N. COVID-19: a review. Monaldi Arch Chest Dis 2020; 90(2). WHO. Coronavirus disease 2019 (COVID-19) Situation Report – 40. Available at: https://covid19.who.int
  4. Mousavizadeh, L., & Ghasemi, S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2020; https://doi.org/10.1016/j.jmii.2020.03.022.
  5. Hassan, S. S., Choudhury, P. P., & Roy, B. Molecular phylogeny and missense mutations of envelope proteins across coronaviruses. Genomics 2020; 112(6): 4993–5004.
  6. Ge, H., Wang, X., Yuan, X et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020; 14:1–9.
  7. Li, H., Liu, S. M., Yu, X. H et al. Coronavirus disease 2019 (COVID-19): current status and future perspective. Int J Antimicrob Agents. 2020; 55(5):105951. Nikolich-Zugich, J., Knox, K. S., Rios, C. T et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience; 2020; 42(2): 505–514.
  8. Jin, Y., Yang, H., Ji, W et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 2020; 12(4), 372. Fan, C., Li, K., Ding, Y et al. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection. MedRxiv 2020; 53:66-70. https://doi.org/10.1101/2020.02.12.20022418
  9. Ye, Q., Wang, B., & Mao, J. The pathogenesis and treatment of theCytokine Storm'in COVID-19. J Infect 2020; 80(6), 607-613.
  10. Mahmudpour, M., Roozbeh, J., Keshavarz M et al. COVID-19 cytokine storm: The anger of inflammation. Cytokine 2020; 155151. Ragab, D., Salah Eldin, H., Taeimah et al. The COVID-19 cytokine storm; what we know so far. Front Immunol 2020; 11, 1446. Touma, M. COVID-19: molecular diagnostics overview. J Mol Med (